Tracy Y.

Lonza Biologics, CDMO services from late phase drug discovery to market supply, from drug substance to drug product across a variety of molecule types.

Drive the adoption of Lonza's expression technologies by US East Coast pharma and biotech innovators

CDMO capabilities: 1. Gene and cell therapy: plasmid and virus production from preclinical to commercialization 2. Therapeutic antibody: - Antibody discovery technologies: hybridoma, phage display, single B cell high throughput screening, fully human naïve library, transgenic animal Ab discovery technology, and bispecific antibody - Fully Integrated Biologics Development Platform: cell line development, process development, analytical development, GMP manufacturing, QA/QC, and regulatory affairs

- Multi-channel marketing: exhibitions, webinars, social media, Podcast, publishers, and third-party advertising - Conduct market research and data analysis to develop channel and commercialization strategy - Engage key opinion leaders (KOLs), and invite KOLs to speak at major congresses (company symposium, AACR, PEGS, Peptalk, iGEM, SITC) and webinars - Curate marketing programs to deliver branding message, drive sales, and increase awareness: Podcast, iGEM sponsorship competition, webinar series, citation program - Organized the 1st GenScript Double Helix Symposium

- Top Region with highest Sales achievements, multi-million dollar sales - Lead a team of 10+ members to grow US Southeast region - Recruited, trained and managed three territory sales managers - Region: AL, GA, FL, SC, VA, NC, MD, DC, TN, KY, WV, AR, LA, MS - Portfolio: Reagent services (Molecular Biology services, Peptide services, Protein expression and purification services, Reagent antibody services, Antibody drug development services) and catalog products. - Customer applications: infectious disease, cancer immunotherapy, cell therapy, gene therapy, biologics, synthetic biology, genome editing, plant biology, animal health

- Top performer, consistently delivered the highest sales achievement and YOY growth. - Territory: Maryland and DC. - Portfolio: Reagent services (molecular biology, peptide, protein expression and purification, reagent antibody, antibody drug development), and catalog products.

Territory: Mid-West and West Coast Portfolio: Sanger Sequencing service, reagent services, and catalog products.

Clinical trial management

Independent research projects: protein interactions of different transcription factors such as Islet-1, PITX2, and Dlx2, which regulate the complex process of tooth development. Skills and techniques: molecular cloning, plasmid preparation, protein expression and purification, Western Blot, IHC, Chromatin immunoprecipitation (CHIP), GST pulldown, cell culture

Healthcare Management; Health Economics; Healthcare Finance; Healthcare policy; Health IT; Biostatistics; Epidemiology; Behavioral Science.

Thesis: "Molecular Mechanisms of Islet-1 in Regulating Craniofacial Development". Courses: Molecular Biology, Genetics, Cell Biology, Biochemistry, Cancer Biology, Developmental Biology.